Service Description
Quantitative proteomics refers to the identification and quantification analysis of proteins in two or more samples to obtain the differential expression and function information of relevant proteins. It plays an important research role in the prevention, diagnosis, prognosis and efficacy monitoring of diseases, and can be used to help develop new therapeutic drugs.
Liquid chromatography – tandem mass spectrometry (LC-MS/MS) is currently the best method for unbiased, high-throughput proteomics analysis. In contrast to label-dependent quantitative proteomics such as the iTRAQ method, label-free data-dependent acquisition (DDA) proteomics doesn’t need to use expensive a stable isotope for labeling of proteins. This allows accurate protein quantification of samples without additional error-prone in vitro labelling reactions and enables fast proteome identification and quantification.
In a typical DDA analysis, the mass spectrometer generates a full-scan mass spectra to determine the molecular weights of peptides and then acquires MS/MS spectra on the N most intense peptide ions. Hundreds of MS/MS spectra can be generated in a single run and downstream data analysis tools are applied for peptide identification and quantification. Since the peptides selected for fragmentation are usually the most abundant peaks in the survey scan, it is easy to cause the loss of low abundance peptides.
